D-0840-2026 Class III Ongoing
FDA drug recall D-0840-2026 was initiated by American Health Packaging on August 19, 2026 and is designated Class III. Reason for recall: Labeling: Label Mix-up The recall status is ongoing. Affected quantity: 10,953 cartons..
Recall Details
- Product Type
- Drugs
- Report Date
- September 9, 2026
- Initiation Date
- August 19, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,953 cartons.
Product Description
Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).
Reason for Recall
Labeling: Label Mix-up
Distribution Pattern
US Nationwide.
Code Information
Lot # 1030023, Exp Date: 06/30/2027.